Patents by Inventor Emil M. Orozco

Emil M. Orozco has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6747189
    Abstract: The current invention provides the Zea mays GRP (ZMGRP) promoter. Compositions comprising this sequence are described, as are plants transformed with such compositions. Further provided are methods for the expression of transgenes in plants comprising the use of these sequences. The methods of the invention include the direct creation of transgenic plants with the ZMGRP promoter by genetic transformation, as well as by plant breeding methods. The sequences of the invention represent a valuable new tool for the creation of transgenic plants, preferably having one or more added beneficial characteristics.
    Type: Grant
    Filed: March 21, 2000
    Date of Patent: June 8, 2004
    Assignee: DeKalb Genetics Corporation
    Inventors: David McElroy, Emil M. Orozco, Jr., Lucille B. Laccetti
  • Publication number: 20040107462
    Abstract: This invention relates to an isolated nucleic acid fragment encoding a sucrose phosphate synthase. The invention also relates to the construction of a chimeric gene encoding all or a portion of the sucrose phosphate synthase, in sense or antisense orientation, wherein expression of the chimeric gene results in production of altered levels of the sucrose phosphate synthase in a transformed host cell.
    Type: Application
    Filed: August 14, 2003
    Publication date: June 3, 2004
    Inventors: Stephen M. Allen, Perry G. Caimi, Emil M. Orozco
  • Publication number: 20040048382
    Abstract: This invention relates to an isolated nucleic acid fragment encoding a hemicellulose biosynthesis protein. The invention also relates to the construction of a chimeric gene encoding all or a portion of the hemicellulose biosynthesis protein, in sense or antisense orientation, wherein expression of the chimeric gene results in production of altered levels of the hemicellulose biosynthesis protein in a transformed host cell.
    Type: Application
    Filed: August 26, 2002
    Publication date: March 11, 2004
    Applicant: E. I. du Pont de Nemours & Co.
    Inventors: Emil M. Orozco, Saverio Carl Falco
  • Patent number: 6677502
    Abstract: This invention relates to an isolated nucleic acid fragment encoding a GTP cyclohydrolase II/3,4-dihydroxy-2-butanone-4-phosphate synthase protein. The invention also relates to the construction of a chimeric gene encoding all or a substantial portion of the protein, in sense or antisense orientation, wherein expression of the chimeric gene results in production of altered levels of the protein in a transformed host cell.
    Type: Grant
    Filed: July 12, 2000
    Date of Patent: January 13, 2004
    Assignees: E.I. du Pont de Nemours and Company, Pioneer Hi-Bred International
    Inventors: Stephen M. Allen, Anthony J. Kinney, J. Antoni Rafalski, Emil M. Orozco, Jr., Guo-Hua Miao, Omolayo O. Famodu, Jian-Ming Lee, Karin N. Lohman, Alan R. Rendina, Hajime Sakai, Zude Weng, Perry G. Caimi, Yiwen Fang, Jennie Bih-Jien Shen, Ilham L. Zoughi, Shawn L. Anderson, Jinrui Shi, Guihua Lu, Timothy G. Helentjaris, Chun Ping Li
  • Publication number: 20030229914
    Abstract: This invention relates to an isolated nucleic acid fragment encoding a sterol metabolism enzyme. The invention also relates to the construction of a chimeric gene encoding all or a portion of the sterol metabolism enzyme, in sense or antisense orientation, wherein expression of the chimeric gene results in production of altered levels of the sterol metabolism enzyme in a transformed host cell.
    Type: Application
    Filed: August 21, 2002
    Publication date: December 11, 2003
    Inventors: Omolayo O. Famodu, Emil M. Orozco, J. Antoni Rafalski, Jennie B. Shen
  • Publication number: 20030229916
    Abstract: This invention relates to an isolated nucleic acid fragment encoding a phosphoribosylaminoimidazole carboxylase. The invention also relates to the construction of a recombinant DNA construct or chimeric gene encoding all or a portion of the phosphoribosylaminoimidazole carboxylase, in sense or antisense orientation, wherein expression of the recombinant DNA construct or chimeric gene results in production of altered levels of the phosphoribosylaminoimidazole carboxylase in a transformed host cell.
    Type: Application
    Filed: December 19, 2002
    Publication date: December 11, 2003
    Inventors: Stephen M. Allen, Emil M. Orozco, Jian-Ming Lee
  • Patent number: 6653099
    Abstract: This invention relates to an isolated nucleic acid fragment encoding a hemicellulose biosynthesis protein. The invention also relates to the construction of a chimeric gene encoding all or a portion of the hemicellulose biosynthesis protein, in sense or antisense orientation, wherein expression of the chimeric gene results in production of altered levels of the hemicellulose biosynthesis protein in a transformed host cell.
    Type: Grant
    Filed: October 29, 1999
    Date of Patent: November 25, 2003
    Assignee: E. I. du Pont de Nemours and Company
    Inventors: Omolayo O. Famodu, Emil M. Orozco, Jr.
  • Publication number: 20030192073
    Abstract: This invention relates to an isolated nucleic acid fragment encoding a biotin synthases. The invention also relates to the construction of a chimeric gene encoding all or a portion of the biotin synthases, in sense or antisense orientation, wherein expression of the chimeric gene results in production of altered levels of the biotin synthases in a transformed host cell.
    Type: Application
    Filed: May 7, 2003
    Publication date: October 9, 2003
    Inventors: Stephen M. Allen, Anthony J. Kinney, Guo-Hua Miao, Emil M. Orozco
  • Publication number: 20030177522
    Abstract: This invention relates to an isolated nucleic acid fragment encoding a folate biosynthetic enzyme. The invention also relates to the construction of a chimeric gene encoding all or a portion of the folate biosynthetic enzyme, in sense or antisense orientation, wherein expression of the chimeric gene results in production of altered levels of the folate biosynthetic enzyme in a transformed host cell.
    Type: Application
    Filed: April 17, 2003
    Publication date: September 18, 2003
    Inventors: Emil M. Orozco, Zude Weng, Leslie T. Harvell
  • Publication number: 20030170845
    Abstract: This invention relates to an isolated nucleic acid fragment encoding a tetrahydrofolate metabolic enzyme. The invention also relates to the construction of a chimeric gene encoding all or a portion of the tetrahydrofolate metabolic enzyme, in sense or antisense orientation, wherein expression of the chimeric gene results in production of altered levels of the tetrahydrofolate metabolic enzyme in a transformed host cell.
    Type: Application
    Filed: June 25, 2002
    Publication date: September 11, 2003
    Inventors: Omolayo O. Famodu, Emil M. Orozco
  • Publication number: 20030167503
    Abstract: This invention relates to isolated nucleic acid fragments encoding pantothenate synthetases. The invention also relates to the construction of chimeric genes encoding all or a portion of the pantothenate synthetases, in sense or antisense orientation, wherein expression of the chimeric genes results in production of altered levels of the pantothenate synthetases in transformed host cells.
    Type: Application
    Filed: November 13, 2001
    Publication date: September 4, 2003
    Inventors: Steven Gutteridge, Leslie T. Harvell, Emil M. Orozco
  • Patent number: 6583338
    Abstract: The current invention provides the maize A3 promoter and actin 2 intron. Compositions comprising these sequences are described, as well as transformation constructs derived therefrom. Further provided are methods for the expression of transgenes in plants comprising the use of these sequences. The methods of the invention include the direct creation of transgenic plants with the A3 promoter directly by genetic transformation, as well as by plant breeding methods. The sequences of the invention represent a valuable new tool for the creation of transgenic plants, preferably having one or more added beneficial characteristics.
    Type: Grant
    Filed: May 7, 2001
    Date of Patent: June 24, 2003
    Assignee: DeKalb Genetics Corporation
    Inventors: David McElroy, Alan L. Kriz, Emil M. Orozco, Jr., Matt Griffor
  • Publication number: 20030114655
    Abstract: The present invention relates to an isolated nucleic acid fragment encoding a phytochelatin synthase. The invention also relates to the construction of a recombinant DNA construct encoding all or a portion of the phytochelatin synthase, in sense or antisense orientation, wherein expression of the recombinant DNA construct results in production of altered levels of the phytochelatin synthase in a transformed host cell.
    Type: Application
    Filed: August 7, 2002
    Publication date: June 19, 2003
    Inventors: Karlene H. Butler, Omolayo O. Famodu, Leslie T. Harvell, Emil M. Orozco, Sonriza Rasco-Gaunt, Catherine J. Thorpe
  • Publication number: 20030104593
    Abstract: This invention relates to an isolated nucleic acid fragment encoding a sorbitol biosynthetic enzyme. The invention also relates to the construction of a chimeric gene encoding all or a portion of the sorbitol biosynthetic enzyme, in sense or antisense orientation, wherein expression of the chimeric gene results in production of altered levels of the sorbitol biosynthetic enzyme in a transformed host cell.
    Type: Application
    Filed: June 15, 2001
    Publication date: June 5, 2003
    Inventors: Omolayo O. Famodu, William D. Hitz, Emil M. Orozco
  • Publication number: 20030087369
    Abstract: This invention relates to isolated nucleic acid fragments encoding granule-bound starch synthase. The invention also relates to the construction of a recombinant DNA construct encoding all or a portion of the granule-bound starch synthase, in sense or antisense orientation, wherein expression of the recombinant DNA construct results in production of altered levels of the granule-bound starch synthase in a transformed host cell.
    Type: Application
    Filed: May 2, 2002
    Publication date: May 8, 2003
    Inventors: Karen E. Broglie, Karlene H. Butler, Leslie T. Harvell, Jonathan E. Lighter, Emil M. Orozco
  • Patent number: 6559354
    Abstract: This invention relates to an isolated nucleic acid fragment encoding a transcription or gene expression regulator. The invention also relates to the construction of a chimeric gene encoding all or a portion of the transcription or gene expression regulator, in sense or antisense orientation, wherein expression of the chimeric gene results in production of altered levels of the transcription or gene expression regulator in a transformed host cell.
    Type: Grant
    Filed: October 27, 2000
    Date of Patent: May 6, 2003
    Assignee: E. I. du Pont de Nemours and Company
    Inventors: Hongchang Ma, Omolayo O. Famodu nee Morakinyo, Joan T. Odell, Emil M. Orozco, Jr., J. Antoni Rafalski
  • Publication number: 20030082787
    Abstract: This invention relates to isolated nucleic acid fragments encoding phosphoribosylformimino-5-aminoimidazole carboxamide ribotide isomerases, or “HisA enzymes”. The invention also relates to the construction of a recombinant DNA construct encoding all or a portion of the HisA enzyme, in sense or antisense orientation, wherein expression of the recombinant DNA construct results in production of altered levels of the HisA enzyme in a transformed host cell.
    Type: Application
    Filed: June 18, 2002
    Publication date: May 1, 2003
    Inventors: Lynn M. Abell, Stephen M. Allen, Karlene H. Butler, Rebecca E. Cahoon, Howard P. Hershey, Emil M. Orozco
  • Publication number: 20020182704
    Abstract: This invention relates to an isolated nucleic acid fragment encoding a proteinase. The invention also relates to the construction of a chimeric gene encoding all or a portion of the proteinase, in sense or antisense orientation, wherein expression of the chimeric gene results in production of altered levels of the proteinase in a transformed host cell.
    Type: Application
    Filed: February 15, 2002
    Publication date: December 5, 2002
    Inventors: Saverio Carl Falco, Edgar B. Cahoon, Omolayo O. Famodu, Theodore M. Klein, Emil M. Orozco, J. Antoni Rafalski, Jennie Bih-Jien Shen, Hajime Sakai
  • Patent number: 6437217
    Abstract: The current invention provides the maize RS81 promoter. Compositions comprising this sequence are described, as are plants transformed with such compositions. Further provided are methods for the expression of transgenes in plants comprising the use of these sequences. The methods of the invention include the direct creation of transgenic plants with the RS81 promoter by genetic transformation, as well as by plant breeding methods. The sequences of the invention represent a valuable new tool for the creation of transgenic plants, preferably having one or more added beneficial characteristics.
    Type: Grant
    Filed: November 30, 2000
    Date of Patent: August 20, 2002
    Assignee: Dekalb Genetics Corporation
    Inventors: David McElroy, Emil M. Orozco, Jr., Lucille B. Laccetti
  • Patent number: 6436657
    Abstract: This invention relates to an isolated nucleic acid fragment encoding a tetrahydrofolate metabolic enzyme. The invention also relates to the construction of a chimeric gene encoding all or a portion of the tetrahydrofolate metabolic enzyme, in sense or antisense orientation, wherein expression of the chimeric gene results in production of altered levels of the tetrahydrofolate metabolic enzyme in a transformed host cell.
    Type: Grant
    Filed: December 17, 1999
    Date of Patent: August 20, 2002
    Assignee: E. I. du Pont de Nemours and Company
    Inventors: Omolayo O. Famodu, Emil M. Orozco, Jr.